Related references
Note: Only part of the references are listed.Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
Rajesh Pradhan et al.
PHARMACEUTICS (2023)
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+Cancers
Kinga Zelechowska-Matysiak et al.
MOLECULES (2023)
Near-infrared upconversion multimodal nanoparticles for targeted radionuclide therapy of breast cancer lymphatic metastases
Chuan Zhang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment
Michal Zuk et al.
PHARMACEUTICS (2022)
Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of 193mPt and 195mPt Radionuclides in Auger Electron Therapy
Kamil Wawrowicz et al.
MOLECULES (2021)
Hybrid System for Local Drug Delivery and Magnetic Hyperthermia Based on SPIONs Loaded with Doxorubicin and Epirubicin
Dorota Nieciecka et al.
PHARMACEUTICS (2021)
131I-labeled and DOX-loaded multifunctional nanoliposomes for radiotherapy and chemotherapy in brain gliomas
Jingmei Gao et al.
BRAIN RESEARCH (2020)
Encapsulation for Cancer Therapy
Xavier Montane et al.
MOLECULES (2020)
Trastuzumab-Modified Gold Nanoparticles Labeled with 211At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer
Lucja Dziawer et al.
NANOMATERIALS (2019)
Folate-Functionalized Lipid Nanoemulsion to Deliver Chemo-Radiotherapeutics Together for the Effective Treatment of Nasopharyngeal Carcinoma
Ying Liu et al.
AAPS PHARMSCITECH (2017)
Mangiferin functionalized radioactive gold nanoparticles (MGF-198AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy
A. Y. Al-Yasiri et al.
DALTON TRANSACTIONS (2017)
Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticles
Desiree Van Haute et al.
THERAPEUTIC DELIVERY (2017)
Triple Therapy of HER2+ Cancer Using Radiolabeled Multifunctional Iron Oxide Nanoparticles and Alternating Magnetic Field
Hamidreza Zolata et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2016)
The case for combined chemotherapy-peptide receptor radionuclide therapy (chemo-PRRT) strategy in metastatic neuroendocrine tumor: predicting and looking at the possible case scenarios
Sandip Basu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies
Jolanda Spadavecchia et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-time
NamHuk Baek et al.
ONCOTARGETS AND THERAPY (2016)
CA4-loaded doxorubicin prodrug coating Fe3O4 nanoparticles for tumor combination therapy
Hongmei Liu et al.
RSC ADVANCES (2016)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Effectiveness of immune therapy combined with chemotherapy on the immune function and recurrence rate of cervical cancer
Bin Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Optimization of Aqueous Biphasic Tumor Spheroid Microtechnology for Anti-cancer Drug Testing in 3D Culture
Stephanie Lemmo et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2014)
Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor of apoptosis protein and B-cell lymphoma-extra large
Claudia Friesen et al.
EUROPEAN JOURNAL OF CANCER (2013)
Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5-fluorouracil chemotherapy in the B16 melanoma model
Xiaoyi Qu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody
Marek Pruszynski et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Role of Antibody-Mediated Tumor Targeting and Route of Administration in Nanoparticle Tumor Accumulation in Vivo
Niladri Chattopadhyay et al.
MOLECULAR PHARMACEUTICS (2012)
Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer
Ravi Shukla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration
Stephanie Hirn et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
In vivo biodistribution of nanoparticles
Joao Paulo Mattos Almeida et al.
NANOMEDICINE (2011)
Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats
Suresh K. Balasubramanian et al.
BIOMATERIALS (2010)
Folate-Receptor-Targeted Delivery of Doxorubicin Using Polyethylene Glycol-Functionalized Gold Nanoparticles
Bahareh Asadishad et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2010)
Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice
Nripen Chanda et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Doxorubicin Exerts Cytotoxic Effects through Cell Cycle Arrest and Fas-Mediated Cell Death
Hye-Sun Kim et al.
PHARMACOLOGY (2009)
Current experience with mIBG therapy in combination with chemotherapy and radiosensitizers
Mark N. Gaze et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
Nanomedicines and nanotoxicology: some physiological principles
M. C. Garnett et al.
OCCUPATIONAL MEDICINE-OXFORD (2006)
Role of cell cycle in mediating sensitivity to radiotherapy
TM Pawlik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
DNA strand breaks and cell cycle perturbation in Herceptin treated breast cancer cell lines
S Mayfield et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Share Paper
